Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis.
Patel GB, Kudlaty EA, Guo A, Yeh C, Kim MS, Price CPE, Conley D, Grammer LC, Kalhan R, Kern RC, McGrath KG, Tan BK, Rosenberg SR, Schleimer RP, Smith SS, Stevens WW, Welch KC, Peters AT.
Patel GB, et al. Among authors: kudlaty ea.
Allergy Asthma Proc. 2021 Sep 1;42(5):417-424. doi: 10.2500/aap.2021.42.210058.
Allergy Asthma Proc. 2021.
PMID: 34474711
Free PMC article.